findmyKOL

Adrian Vella, MD

Enriched profile

Professor of Medicine, Mayo Clinic College of Medicine and Science; Research Chair, Division of Endocrinology, Diabetes, Metabolism & Nutrition; Director, Mayo Clinic Inpatient Clinical Research and Trials Unit · Mayo Clinic in Rochester

ORCIDNPI
Region🇺🇸 Rochester, MN · Midwest · United StatesSpecialtyEndocrinology, Diabetes & MetabolismFocusType 1 Diabetes+2
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2026Online presenceverified 2026Payments2023–2025NIH funding2007–2026

Adrian Vella is Professor of Medicine, Mayo Clinic College of Medicine and Science; Research Chair, Division of Endocrinology, Diabetes, Metabolism & Nutrition; Director, Mayo Clinic Inpatient Clinical Research and Trials Unit at Mayo Clinic in Rochester. OpenAlex indexes 361 publications with 14,831 citations (h-index 64); ClinicalTrials.gov lists 30 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 10% of Endocrinology, Diabetes & Metabolism profiles in the findmyKOL directory.

Data verified 14 Aug 2026

Overview

Updated 27 Aug 2026

Adrian Vella, MD, is Professor of Medicine, Mayo Clinic College of Medicine and Science at Mayo Clinic in Rochester, Minnesota. The public record shows 361 publications with 14,831 citations (h-index 64), centered on Type 1 Diabetes, Obesity, Type 2 Diabetes. It also documents an investigator role on 30 registered clinical trials, industry payments reported by 2 companies, 4 NIH-funded awards (2007–2026).

  • Most recent indexed publication: 2026 · Diabetes care
  • Top research focus: Type 1 Diabetes
  • 30 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 2 companies

Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Type 2 Diabetes12 trialsObesity7 trialsPrediabetic State3 trialsType 1 Diabetes2 trialsNASH / NAFLD / MASH1 trialNon-alcoholic Fatty Liver Disease1 trialGenetic Predisposition to Disease1 trial

Research focus

OpenAlex concept fingerprint
Type 1 DiabetesObesityType 2 Diabetes

Works with

trial sponsors and companies reporting payments
Mayo ClinicClinical trials19Industry paymentsBoehringer Ingelheim International GmbHClinical trialsIndustry payments10Adrian VellaClinical trials9Industry payments

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
361publications

Distinct works indexed by OpenAlex, matched via ORCID; 41 in PubMed.

14,831citations

Total citations across indexed works.

64h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
30clinical trials

Investigator role on registered studies.

View trials
2companies · 2023–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments
4NIH grants · 2007–2026

Federally funded research awards.

View funding

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 27 Aug 2026

Listed as an investigator on 30 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 27 Aug 2026

2 companies reported payments to CMS in program years 2023–2025. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Metabolism & gastrointestinal

    46.2%
    Insulin Analog18.7%
    Lantus Solostar46%Humalog Kwikpen U-10031%Tresiba Flextouch U-10023%
    Part D<11 patients
    GLP-1 receptor agonist17.1%
    Mounjaro50%Ozempic50%
    Part D<11 patients
  • Cardiovascular

    17.4%
    ACE inhibitor7.3%
    Lisinopril100%
    Part D<11 patients
    Statin6.7%
    Atorvastatin Calcium100%
    Part D<11 patients
  • Hormonal (systemic)

    12.5%
    l-Thyroxine12.5%
    Levothyroxine Sodium100%
    Part D13 patients
3 more therapeutic areas behind the reveal.Reveal →
Where care is delivered (Part B)0% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

Updated 27 Aug 2026

4 NIH research awards on record, funded 20072026 per NIH RePORTER. The latest:

Publications

Updated 27 Aug 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

Online presence

Updated 27 Aug 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • Doximity

    doximity.com/pub/adrian-vella-md

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com

Mentions by others

where others cite or feature them
  • Instagram

    instagram.com/mayoclinic/p/B881TxBnAV6

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →instagram.com
  • Other

    diabetesjournals.org/care/article/47/7/1101/156873/About-the-Artist-Adrian-Vella-MD

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →diabetesjournals.org
  • Other

    emedevents.com/speaker-profile/adrian-vella

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →emedevents.com
1 more mention behind the reveal.Reveal →

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 27 Aug 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record
  • Clinician-Investigator track

    Endocrine Fellowship, Mayo Clinic Rochester

    2001
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mayo.edu
  • Internal Medicine Residency

    Mayo Clinic Rochester

    1998
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →alumniassociation.mayo.edu
  • M.D.

    University of Malta Medical School

    1993
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mayo.edu
  • Board Certified

    American Board of Internal Medicine, Endocrinology, Diabetes and Metabolism

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mayo.edu

Editorial & leadership roles

journal and society appointments
  • Research Chair

    Division of Endocrinology, Diabetes, Metabolism & Nutrition, Mayo Clinic

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mayo.edu
  • Director

    Mayo Clinic Inpatient Clinical Research and Trials Unit

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →alumniassociation.mayo.edu
  • Member

    American Society for Clinical Investigation

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →the-asci.org
1 more role behind the reveal.Reveal →

Awards & honors

honors on the public record
  • Elected Member

    American Society for Clinical Investigation

    2019
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →the-asci.org
  • Inaugural Awardee

    Mayo Brothers Distinguished Fellowship Award

    1997
    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →health.usnews.com

Secondary affiliations

appointments beyond the home institution

Media & interviews

press, podcasts and appearances

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.